GlyciHalt MV1
Voglibose, Glimepiride and Metformin Hydrochloride (Sustained Release) Tablets
Composition
- Voglibose IP — 0.2 mg
- Glimepiride IP — 1 mg
- Metformin Hydrochloride IP — 500 mg (as sustained release form)
- Dosage Form
- Bilayered Tablet (Sustained Release)
- Pack
- 10 x 10 Tablets
- MRP
- ₹135.00 per 10 tablets (incl. all taxes)
- Colour
- Red Oxide of Iron
- Storage
- Store protected from light and moisture, at a temperature not exceeding 30°C.
SCHEDULE H & G DRUG — WARNING: It is dangerous to take this preparation except under medical supervision. To be sold by retail on the prescription of a Registered Medical Practitioner only.
Marketed by
Stemgrow Pharmaceuticals
Manufactured by
Bioaltus Pharmaceuticals Pvt. Ltd.
19-20, DIC, Ind. Area, Baddi, Distt. Solan, (H.P.) 173205 — WHO-GMP Certified
Mfg. Lic. No. L/16/1795/MNB
Frequently asked questions
Product information for healthcare professionals, pharmacists and distributors.
What is the composition of GlyciHalt MV1?
Each bilayered tablet (sustained release) of GlyciHalt MV1 contains Voglibose IP — 0.2 mg; Glimepiride IP — 1 mg; Metformin Hydrochloride IP — 500 mg (as sustained release form).
Is GlyciHalt MV1 a prescription product?
GlyciHalt MV1 is a Schedule H & G drug. It is dangerous to take this preparation except under medical supervision, and it must be sold by retail only on the prescription of a Registered Medical Practitioner.
What pack size and MRP does GlyciHalt MV1 come in?
GlyciHalt MV1 is supplied as 10 x 10 Tablets. MRP: ₹135.00 per 10 tablets (incl. all taxes).
How should GlyciHalt MV1 be stored?
Store protected from light and moisture, at a temperature not exceeding 30°C. Keep out of reach of children.
Who manufactures and markets GlyciHalt MV1?
GlyciHalt MV1 is marketed by Stemgrow Pharmaceuticals and manufactured by Bioaltus Pharmaceuticals Pvt. Ltd., 19-20, DIC, Ind. Area, Baddi, Distt. Solan, (H.P.) 173205 — WHO-GMP Certified (Mfg. Lic. No. L/16/1795/MNB).
Which therapeutic category does GlyciHalt MV1 belong to?
GlyciHalt MV1 belongs to the Anti-Diabetic range from Stemgrow Pharmaceuticals — Voglibose, Glimepiride and Metformin Hydrochloride (Sustained Release) Tablets.
